Nora Therapeutics Overview
- Year Founded
-
1992
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Nora Therapeutics General Information
Description
Provider of biotechnology platform intended to develop therapeutics to address unmet needs in reproductive medicine. The company's platform develops therapeutics to address IVF failure and recurrent pregnancy loss in women who have a history of unexplained recurrent miscarriage, enabling physicians to help their patients in embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance.
Contact Information
Website
www.noratherapeutics.comCorporate Office
- 530 Lytton Avenue
- 2nd floor
- Palo Alto, CA 94301
- United States
Corporate Office
- 530 Lytton Avenue
- 2nd floor
- Palo Alto, CA 94301
- United States
Nora Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Jan-2017 | Completed | Out of Business | |||
| 3. Later Stage VC | 13-Oct-2015 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 17-Apr-2014 | $18M | $52.9M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 01-Sep-2010 | $34.9M | $34.9M | Completed | Product Development |
Nora Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Nora Therapeutics Patents
Nora Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015057724-A1 | Use of g-csf for treating or preventing villitis of unknown etiology in a human female | Inactive | 14-Oct-2013 | ||
| WO-2010126528-A1 | Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination | Inactive | 01-May-2009 | ||
| WO-2010126528-A9 | Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination | Inactive | 01-May-2009 | ||
| WO-2010126553-A1 | Compositions and methods for reducing the likelihood of implantation failure or spontaneous abortion in recipients of assisted reproduction | Inactive | 01-May-2009 | ||
| EP-2274325-A1 | Human g-csf analogs and methods of making and using thereof | Inactive | 13-May-2008 | C07K14/535 |
Nora Therapeutics FAQs
-
When was Nora Therapeutics founded?
Nora Therapeutics was founded in 1992.
-
Where is Nora Therapeutics headquartered?
Nora Therapeutics is headquartered in Palo Alto, CA.
-
What industry is Nora Therapeutics in?
Nora Therapeutics’s primary industry is Pharmaceuticals.
-
Is Nora Therapeutics a private or public company?
Nora Therapeutics is a Private company.
-
What is Nora Therapeutics’s current revenue?
The current revenue for Nora Therapeutics is .
-
How much funding has Nora Therapeutics raised over time?
Nora Therapeutics has raised $53.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process